Baptiste Plion
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Erratum: Efficacy and safety of SENS-501, a dual-AAV otoferlin gene therapy, for DFNB9 congenital deafness.
Journal: Molecular therapy. Advances
Published: August 07, 2026
Efficacy and safety of SENS-501, a dual-AAV otoferlin gene therapy, for DFNB9 congenital deafness.
Journal: Molecular therapy. Advances
Published: December 04, 2025
MYO7A is required for the functional integrity of the mechanoelectrical transduction complex in hair cells of the adult cochlea.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: January 02, 2025
Cochlear gene therapy restores hearing and auditory processing in an atypical DFNB9 mouse model.
Journal: Communications medicine
Published: September 24, 2024
A free intravesicular C-terminal of otoferlin is essential for synaptic vesicle docking and fusion at auditory inner hair cell ribbon synapses.
Journal: Progress in neurobiology
Published: March 21, 2024
Showing 1-8 of 8
Last Updated: 09/26/2026